151 related articles for article (PubMed ID: 24586227)
1. HIV infection of hepatocytes results in a modest increase in hepatitis C virus expression in vitro.
Kong L; Welge JA; Powell EA; Blackard JT
PLoS One; 2014; 9(2):e83728. PubMed ID: 24586227
[TBL] [Abstract][Full Text] [Related]
2. CCR5 receptor antagonism inhibits hepatitis C virus (HCV) replication in vitro.
Blackard JT; Kong L; Rouster SD; Karns R; Horn PS; Kottilil S; Shata MT; Sherman KE
PLoS One; 2019; 14(10):e0224523. PubMed ID: 31661521
[TBL] [Abstract][Full Text] [Related]
3. Low-level HIV infection of hepatocytes.
Kong L; Cardona Maya W; Moreno-Fernandez ME; Ma G; Shata MT; Sherman KE; Chougnet C; Blackard JT
Virol J; 2012 Aug; 9():157. PubMed ID: 22877244
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C Virus Infection of Human Thyrocytes: Metabolic, Hormonal, and Immunological Implications.
Hammerstad SS; Blackard JT; Lombardi A; Owen RP; Concepcion E; Yi Z; Zhang W; Tomer Y
J Clin Endocrinol Metab; 2020 Apr; 105(4):1157-68. PubMed ID: 31784757
[TBL] [Abstract][Full Text] [Related]
5. Effects of HCV on basal and tat-induced HIV LTR activation.
Sengupta S; Powell E; Kong L; Blackard JT
PLoS One; 2013; 8(6):e64956. PubMed ID: 23762271
[TBL] [Abstract][Full Text] [Related]
6. A preliminary analysis of hepatitis C virus in pancreatic islet cells.
Blackard JT; Kong L; Lombardi A; Homann D; Hammerstad SS; Tomer Y
Virol J; 2017 Dec; 14(1):237. PubMed ID: 29258547
[TBL] [Abstract][Full Text] [Related]
7. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.
Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S
Virol J; 2016 Apr; 13():59. PubMed ID: 27044429
[TBL] [Abstract][Full Text] [Related]
8. Contradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV.
El Sobky SA; El-Ekiaby NM; Mekky RY; Elemam NM; Mohey Eldin MA; El-Sayed M; Esmat G; Abdelaziz AI
Immunol Lett; 2016 Jan; 169():52-60. PubMed ID: 26518141
[TBL] [Abstract][Full Text] [Related]
9. The synthetic opioid fentanyl enhances viral replication in vitro.
Kong L; Karns R; Shata MTM; Brown JL; Lyons MS; Sherman KE; Blackard JT
PLoS One; 2021; 16(4):e0249581. PubMed ID: 33852610
[TBL] [Abstract][Full Text] [Related]
10. HIV infection increases HCV-induced hepatocyte apoptosis.
Jang JY; Shao RX; Lin W; Weinberg E; Chung WJ; Tsai WL; Zhao H; Goto K; Zhang L; Mendez-Navarro J; Jilg N; Peng LF; Brockman MA; Chung RT
J Hepatol; 2011 Apr; 54(4):612-20. PubMed ID: 21146890
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of native and recombinant full-length camel lactoferrin and its N and C lobes on hepatitis C virus infection of Huh7.5 cells.
Liao Y; El-Fakkarany E; Lönnerdal B; Redwan EM
J Med Microbiol; 2012 Mar; 61(Pt 3):375-383. PubMed ID: 22052996
[TBL] [Abstract][Full Text] [Related]
12. A host cell RNA-binding protein, Staufen1, has a role in hepatitis C virus replication before virus assembly.
Blackham SL; McGarvey MJ
J Gen Virol; 2013 Nov; 94(Pt 11):2429-2436. PubMed ID: 23907398
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes.
Liu JP; Ye L; Wang X; Li JL; Ho WZ
Transpl Infect Dis; 2011 Feb; 13(1):24-32. PubMed ID: 21040279
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus infection triggers a tumor-like glutamine metabolism.
Lévy PL; Duponchel S; Eischeid H; Molle J; Michelet M; Diserens G; Vermathen M; Vermathen P; Dufour JF; Dienes HP; Steffen HM; Odenthal M; Zoulim F; Bartosch B
Hepatology; 2017 Mar; 65(3):789-803. PubMed ID: 27863447
[TBL] [Abstract][Full Text] [Related]
15. The J6JFH1 strain of hepatitis C virus infects human B-cells with low replication efficacy.
Nakai M; Seya T; Matsumoto M; Shimotohno K; Sakamoto N; Aly HH
Viral Immunol; 2014 Aug; 27(6):285-94. PubMed ID: 24853207
[TBL] [Abstract][Full Text] [Related]
16. Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes.
Brownell J; Wagoner J; Lovelace ES; Thirstrup D; Mohar I; Smith W; Giugliano S; Li K; Crispe IN; Rosen HR; Polyak SJ
J Hepatol; 2013 Oct; 59(4):701-8. PubMed ID: 23770038
[TBL] [Abstract][Full Text] [Related]
17. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.
Ikeda M; Yi M; Li K; Lemon SM
J Virol; 2002 Mar; 76(6):2997-3006. PubMed ID: 11861865
[TBL] [Abstract][Full Text] [Related]
18. The effects of hepatitis C virus core protein on the expression of miR-122 in vitro.
Li S; Xing X; Yang Q; Xu H; He J; Chen Z; Zhu H
Virol J; 2013 Mar; 10():98. PubMed ID: 23537271
[TBL] [Abstract][Full Text] [Related]
19. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
[TBL] [Abstract][Full Text] [Related]
20. TRAIL dependent fratricidal killing of gp120 primed hepatocytes by HCV core expressing hepatocytes.
Rizza SA; Challagundla KB; Natesampillai S; Bren GD; Sykora J; Walczak H; Badley AD
PLoS One; 2011; 6(11):e27171. PubMed ID: 22110611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
